Keywords: Prostate, Prostate
Motivation: Pathogenic DDR gene alterations are associated with aggressive disease and poor outcomes among prostate cancer (PCa) patients.
Goal(s): To develop a radiomics-based pre-testing model for identifying DDR mutation carriers among PCa patients.
Approach: A total of 225 patients from three centers with both multiparameter MRI and genetic DDR mutations testing were included. Radiomic models were established based on T2WI and ADC sequences of MRI images. The predictive values were validated in both internal and external validation cohorts.
Results: The radiomics-based model exhibited an AUC of 0.835 in the training dataset, 0.824 in the internal validation dataset, and 0.836 in the external validation dataset.
Impact: In the current study, we introduced a noninvasive radiomics feature-based tool designed to predict pDDRg mutations in prostate cancer patients. External validation of the novel tool by datasets from other medical centers revealed a high predictive accuracy for pDDRg mutations.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords